• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AOMORI OLYMPUS CO., LTD. SINGLE USE MECHANICAL LITHOTRIPTOR V

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AOMORI OLYMPUS CO., LTD. SINGLE USE MECHANICAL LITHOTRIPTOR V Back to Search Results
Model Number BML-V232QR-30
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Abdominal Pain (1685); Cardiac Arrest (1762); Hemorrhage/Blood Loss/Bleeding (1888); Perforation (2001); Pneumonia (2011); Septic Shock (2068); Pancreatitis (4481)
Type of Reportable Event Serious Injury
Event or Problem Description
Olympus reviewed the following literature titled " orlando protocol for single session ductal clearance of common bile duct stones at endoscopic retrograde cholangiopancreatography ".Objectives: approach to management of common bile duct stones (cbds) by endoscopic retrograde cholangiopancreatography (ercp) is not standardized.We examined outcomes by applying predetermined protocol for cbds management.Methods: when standard extraction techniques failed at ercp, presence of tapered bile duct and stone-duct ratio were calculated.Large balloon sphincteroplasty (lbs) and/or mechanical/single-operator cholangioscopy-guided lithotripsy was performed based on presence of tapered bile duct and stone-duct mismatch.Primary outcome was single-session ductal clearance.Secondary outcome was adverse events.Results: of (b)(4) patients treated over 16 months, (b)(4) ((b)(4)) had no tapered bile duct or stone-duct mismatch, and single-session ductal clearance was achieved using standard techniques in (b)(4) over median duration of 14 min (interquartile range [iqr] 9-21 min).Of (b)(4) patients with difficult cbds, tapered duct was seen in (b)(4) and/or stone-duct mismatch in (b)(4)).Single-session ductal clearance was achieved in all (b)(4) by lbs in (b)(4), mechanical lithotripsy in (b)(4), and single-operator cholangioscopy-guided lithotripsy in (b)(4) over a median duration of 29 min (iqr 17-47 min).Overall, single-session ductal clearance was achieved in (b)(4) with adverse events in (b)(4) that included perforation in (b)(4), postsphincterotomy bleeding in one, and mild/moderate post-ercp pancreatitis in (b)(4) patients.Conclusions: a predetermined protocol optimized outcomes by enabling single-session ductal clearance of cbds with high technical success and low adverse events.¿type of adverse events/number of patients.1.Perforation(n=(b)(4)).2.Post sphincterotomy bleeding(n=(b)(4)).3.Mild/moderate post-ercp pancreatitis(n=(b)(4)).(b)(4) patient with duodenal perforation was successfully treated with placement of an over-the-scope clip, which sealed the perforation and confirmed on fluoroscopy.During hospitalization post procedure, the patient aspirated clear liquids, developed aspiration pneumonia, and subsequently had a cardiopulmonary arrest.Supportive care from this patient was withdrawn 7 days after intervention.Admission was needed post-procedure to the treating facility because of acute pancreatitis, perforation, abdominal pain, bleeding.Duodenal perforation was encountered in (b)(4) patients during duodenoscope navigation that were managed endoscopically using over-the-scope clips.A stent was placed in one patient who underwent a successful second ercp for stone extraction.Mild and moderate pancreatitis were encountered in (b)(4) patients, respectively, who were managed conservatively.This report is related to the following linked patient identifiers: (b)(6).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SINGLE USE MECHANICAL LITHOTRIPTOR V
Common Device Name
SINGLE USE MECHANICAL LITHOTRIPTOR
Manufacturer (Section D)
AOMORI OLYMPUS CO., LTD.
2-248-1 okkonoki
kuroishi-shi, aomori 036-0 357
JA  036-0357
MDR Report Key20347777
Report Number2429304-2024-0000429
Device Sequence Number7931410
Product Code LQC
UDI-Device Identifier04953170218361
UDI-Public04953170218361
Combination Product (Y/N)N
Initial Reporter StateFL
Initial Reporter CountryUS
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Importer
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 10/01/2024
Report Date (Section F) 09/02/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model NumberBML-V232QR-30
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Distributor Facility Aware Date09/02/2024
Event Location Hospital
Date Report to Manufacturer09/02/2024
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer Not provided
Initial Report FDA Received Date10/01/2024
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
EXTRACTION BALLOON V, MODEL- B-V232P-A, SN-UNK.
Outcome Attributed to Adverse Event Life Threatening; Hospitalization; Required Intervention;
Patient SexUnknown
-
-